New revolutionary technology – prolongs the lifespan of semen
main picture

SpermVital –
Increasing possibilities

The idea behind the SpermVital technology is to extend the life of spermatozoa after insemination. To achieve this, sperm cells are immobilized in a natural substance before cryopreservation. This immobilization preserves energy and enables a controlled release of sperm cells in the uterus after insemination over an extended period of time. This makes timing of insemination less critical with regards to ovulation in the female, and increases the odds of fertilization success.


New revolutionary technology – prolongs the lifespan of semen



  • Timing of insemination will be less critical.
  • Conception rate will be higher than or at least equal to conventional semen.
  • Inseminations per heat can be reduced.
  • Inseminations on weekends and public holidays can be reduced or avoided altogether.
  • Conventional insemination equipment and technique is used.
    (we recommend 36-38°C for at least 1 minute, and then inseminate as soon as possible)

For the herd owner, this translates to reduced insemination costs and improved herd fertility, both factors that lead to increased profitability.


Latest news

SpermVital is performing well in Austria
SpermVital is performing well in Austria
At the European conference for station veterinarians, AI-vet, in Denmark in October, Dr. Friedrich Führer from the Austrian breeding company Genostar presented field data from the use of SpermVital in the Austrian market.
The company has analyzed field data from 32 herds that have used SpermVital.The data shows that on average SpermVital and regular processed semen is giving the same result in the field, but that there are also individual differences between the farms. Experience from other markets show that is SpermVital is very often used in a different way than regular semen. We often see that it is used when the farmer is uncertain about the time of insemination as well as on problem cows. Therefore, data...
New field trial with Masterrind
New field trial with Masterrind
During the summer and fall of 2019, Masterrind has conducted a field trial where the purpose was to test SpermVital®-semen in comparison with ordinary semen.
The trial gave strong indications that early insemination with SpermVital®-semen has a positive effect on the Non Return Rate. Below are the results from the trial. The field trial was conducted independently by Masterrind, with doses originally produced for sale. The trial included 5 farms. All farms used Heatime systems as a basis for heat detection. In total 440 cows and heifers were inseminated, divided into four groups. Based on the Heatime system, about 50% of the cows and heifers were...
PHD Heidi
PhD in immunology
Heidi Spång, scientist in SpermVital has defended her PhD in immunology
The main thesis of the PhD was to show that vaccines can be made more effective if antigens from infectious agents are connected to targeting units that bind specialized immune cells in our body. Heidi Spång and co-workers have developed a new heterodimeric platform for targeted DNA vaccines that can have two different targeting units and two different antigens. This new vaccine platform provides more flexibility for developing new DNA vaccines against infectious diseases and cancer.